These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 11605176)
21. Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer. Choy H; Akerley W; Safran H; Graziano S; Chung C Semin Oncol; 1996 Dec; 23(6 Suppl 16):117-9. PubMed ID: 9007137 [TBL] [Abstract][Full Text] [Related]
22. Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA/B non-small cell carcinoma of the lung. Antonia SJ; Wagner H; Williams C; Alberts M; Hubbell D; Robinson L; Hilstro J; Ruckdeschel JC Semin Oncol; 1995 Aug; 22(4 Suppl 9):34-7. PubMed ID: 7644926 [TBL] [Abstract][Full Text] [Related]
23. Paclitaxel: a pharmacoeconomic review of its use in non-small cell lung cancer. Plosker GL; Hurst M Pharmacoeconomics; 2001; 19(11):1111-34. PubMed ID: 11735678 [TBL] [Abstract][Full Text] [Related]
25. Ifosfamide and paclitaxel combinations for the treatment of advanced non-small cell lung cancer. Shepherd FA; Eisenhauer E Semin Oncol; 1998 Feb; 25(1 Suppl 2):2-7. PubMed ID: 9535204 [TBL] [Abstract][Full Text] [Related]
26. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline. Chu Q; Vincent M; Logan D; Mackay JA; Evans WK; Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391 [TBL] [Abstract][Full Text] [Related]
27. Weekly paclitaxel/cisplatin with concurrent radiotherapy in patients with locally advanced non-small cell lung cancer: a phase I study. Comella G; Frasci G; Scoppa G; Guida C; Gravina A; Fiore F; Casaretti R; Daponte A; Ruffolo P; Comella P Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-113-S12-116. PubMed ID: 9331134 [TBL] [Abstract][Full Text] [Related]
28. Paclitaxel, carboplatin and radiation therapy for non-small-cell lung cancer. Choy H; Akerley W; Devore R Oncology (Williston Park); 1998 Jan; 12(1 Suppl 2):80-6. PubMed ID: 9516618 [TBL] [Abstract][Full Text] [Related]
29. Preliminary results of two dose-finding studies of paclitaxel (Taxol) and carboplatin in non-small cell lung and ovarian cancers: a European Cancer Centre effort. Giaccone G; Huizing M; ten Bokkel Huinink W; Koolen M; Postmus P; van Kralingen K; van Zandwijk N; Vermorken J; Beijnen J; Dalesio O Semin Oncol; 1994 Oct; 21(5 Suppl 8):34-8. PubMed ID: 7939761 [TBL] [Abstract][Full Text] [Related]
30. A systematic overview of chemotherapy effects in non-small cell lung cancer. Sörenson S; Glimelius B; Nygren P; Acta Oncol; 2001; 40(2-3):327-39. PubMed ID: 11441939 [TBL] [Abstract][Full Text] [Related]
31. Escalating paclitaxel doses combined with carboplatin/etoposide and thoracic radiotherapy as preoperative or definitive treatment for stage III non-small cell lung cancer. Bonomi P; Siddiqui S; Lincoln S; Sharma M; Recine D; Warren W; Faber LP Semin Oncol; 1996 Dec; 23(6 Suppl 16):102-7. PubMed ID: 9007134 [TBL] [Abstract][Full Text] [Related]
32. The current state of paclitaxel and radiation in the combined-modality therapy of non-small cell lung cancer. Choy H; MacRae R Semin Oncol; 2001 Aug; 28(4 Suppl 14):17-22. PubMed ID: 11605179 [TBL] [Abstract][Full Text] [Related]
33. New treatment agents for advanced small cell and non-small cell lung cancer. Bunn PA; Kelly K Semin Oncol; 1995 Jun; 22(3 Suppl 6):53-63. PubMed ID: 7597434 [TBL] [Abstract][Full Text] [Related]